A recombinant adeno-associated virus (RAAV) universal reference standard for determining raav genome copy titer by quantitative PCR

CA3328944A1Undetermined Publication Date: 2025-11-06AGATHOS BIOLOGICS
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CA3328944
Authority / Receiving Office
CA · CA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-04-29
Filing Date
2025-04-29
Publication Date
2025-11-06
Patent Text Reader

Abstract

Disclosed is a recombinant adeno-associated virus (rAAV) vector that is a universal reference standard in quantitative PCR assays used to determine the genome copy titer of rAAV-transgene particles. The rAAV-Universal Standard vector includes multiple nucleotide sequences that are targets for PCR assays to support polymerization such as fragments of commonly used promoters, enhancers, polyadenylation sequences, and reporter genes found in rAAV constructs. Those multiple targets ensure that there is a positive reaction and thus provide a standard, positive control and calibrator to assure proper performance of the quantitative PCR assays without the need to use a separate reference standard for each particular rAAV particle assayed. The rAAV-Universal Standard is produced in multiple AAV serotypes and may encode a functional reporter gene to further provide a universal positive control for analytical assays of rAAV-transgene particles.
Need to check novelty before this filing date? Find Prior Art